LAUSR

© 2020 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. pISSN 2383-7837 eISSN 2383-7845 In a recent case study, Ohba et al. [1] suggested that presence of papillae in absence of other criteria of malignancy and exuberant nuclear alterations (nuclear score 3 [2]) may not be sufficient for diagnosis of papillary thyroid carcinoma (PTC) and proposed the name “noninvasive encapsulated papillary RASlike thyroid tumor” (NEPRAS) to encompass the borderline nature of the diagnosis [1].